CD4 and neoplasm: In mice vaccinated with ENO1 or OVA, the percentage of FoxP3+ Treg cells in total CD4+CD25+ cells of spleens from tumor-bearing mice was significantly increased compared to those from tumor-free mice (Figure 5A).